Skip to main content
. 2023 Oct 7;19(1):184–189. doi: 10.1016/j.jtumed.2023.09.006

Table 2.

Vitamin D receptor immunohistochemical staining analysis in patients with gestational trophoblastic neoplasia or hydatidiform mole.

Diagnosis
Gestational trophoblastic neoplasia (n = 24) Hydatidiform mole (n = 37)
VDR intensity
 Weak 6 (25.0%) 2 (5.4%)
 Moderate 6 (25.0%) 5 (13.6%)
 Strong 12 (50.0%) 30 (81.0%)
VDR distribution
 ≤10% 0 (0.0%) 3 (8.1%)
 11–50% 4 (16.7%) 4 (10.8%)
 51–80% 9 (37.5%) 8 (21.7%)
 >81% 11 (45.8%) 22 (59.4%)

VDR, vitamin D receptor.